News
From APA
Rachel Johnston, Regional Director/ State Government Relations from the APA, provided us with the following headlines from Psychiatric News and an Advocacy update.
Rejoyn: First App Cleared by FDA for Depression; Cost, Efficacy Unclear
Linda M. Richmond
A new smartphone app promises to help treat people who don’t fully respond to their antidepressant. Whether insurance will cover it and whether apps that go through the FDA clearance process will ultimately reach patients remains unclear.
Calls to Poison Centers Involving Psilocybin Rising in Youth
Terri D’Arrigo
Decriminalization, legalization of psilocybin likely play roles in both increased exposure and poisoning.
Advocacy Update:
The second Advocacy Update Webinar is scheduled for 7/30 at noon. Join the Division of Advocacy, Policy, and Practice Advancement on July 30th from12:00-12:45 pm ET to hear the latest updates on APA’s federal, state, and regulatory advocacy. Learn what is happening in Washington, D.C. and the states and how you can fuel our advocacy efforts to create impactful change for our profession and patients. Click here to register.
Newsletter
Events
Monthly UHS Resident and Fellow Webinars
Starting September 10th, 2024 to March 4th, 2025
Click here for more info!
________________________________
PMANM 2024 Fall Conference
SAVE THE DATE
Saturday, November 16, 20204 8AM-12PM
- Embassy Suites, 1000 Woodward Pl NE, Albuquerque, NM 87102
- Free for members, $50 for non-members
- Breakfast included
Details and Registration Coming Soon
Join PMANM
PMANM members receive the clinical updates needed to stay informed, the programs and patient care resources needed to deliver optimal care, and access to meetings, virtual events, and networking opportunities that helps to empower career advancement.